MedPath

Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial

Completed
Conditions
Primary Hyperparathyroidism
Registration Number
NCT00522028
Lead Sponsor
Oslo University Hospital
Brief Summary

The present study is a randomized, controlled trial that investigates the effects of parathyroidectomy or medical observation in mild asymptomatic pHPT on morbidity and quality of life (QoL).

Detailed Description

The patients are included and randomized by block randomization to medical observation or parathyroidectomy by an experienced parathyroid surgeon.

The patients will be followed up for 10 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
191
Inclusion Criteria
  • Untreated, asymptomatic pHPT
  • 2.60>S-Ca<2.85 mmol/liter
  • Age between 50 and 80 yr
  • No medications interfering with Ca-metabolism
  • Informed consent
Exclusion Criteria
  • Hyperparathyroid bone disease
  • Previous operation in the neck
  • Impaired kidney function
  • Kidney stones
  • Complicating medical conditions
  • Psychiatric disorders
  • Multiple endocrine neoplasia,
  • Familial hypocalcuric hypercalcemia
  • Familial HPT

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Oslo University Hospital - Rikshospitalet

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath